TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model.
Immune checkpoint inhibitors have demonstrated, over the recent years, impressive clinical response in cancer patients, but some patients do not respond at all to checkpoint blockade, exhibiting primary resistance. Primary resistance to PD-1 blockade is reported to occur under conditions of immunosu...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7dca81abbfbf4d83b65009791af3b7f8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|